Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

• Main Authors: Claire Vigne (Author), Martin Dupuy (Author), Aline Richetin (Author), Bruno Guy (Author), Nicholas Jackson (Author), Matthew Bonaparte (Author), Branda Hu (Author), Melanie Saville (Author), Danaya Chansinghakul (Author), Fernando Noriega (Author), Eric Plennevaux (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2017-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Two large pivotal phase III studies demonstrated the efficacy of the tetravalent dengue vaccine (CYD-TDV; Dengvaxia®, Sanofi Pasteur) against all dengue serotypes. Here we present an unprecedented integrated summary of the immunogenicity of CYD-TDV to identify the parameters driving the neutralizing...